538 related articles for article (PubMed ID: 35835752)
21. Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study.
Baranova A; Cao H; Zhang F
J Med Virol; 2023 Jan; 95(1):e28107. PubMed ID: 36039844
[TBL] [Abstract][Full Text] [Related]
22. Prioritization of Drug Targets for Neurodegenerative Diseases by Integrating Genetic and Proteomic Data From Brain and Blood.
Ge YJ; Ou YN; Deng YT; Wu BS; Yang L; Zhang YR; Chen SD; Huang YY; Dong Q; Tan L; Yu JT;
Biol Psychiatry; 2023 May; 93(9):770-779. PubMed ID: 36759259
[TBL] [Abstract][Full Text] [Related]
23. The associations between plasma soluble Trem1 and neurological diseases: a Mendelian randomization study.
Shi X; Wei T; Hu Y; Wang M; Tang Y
J Neuroinflammation; 2022 Sep; 19(1):218. PubMed ID: 36068612
[TBL] [Abstract][Full Text] [Related]
24. Five Major Psychiatric Disorders and Alzheimer's Disease: A Bidirectional Mendelian Randomization Study.
Wei T; Guo Z; Wang Z; Li C; Zhu W; Zheng Y; Yin Y; Mi Y; Xia X; Hou H; Tang Y
J Alzheimers Dis; 2022; 87(2):675-684. PubMed ID: 35367968
[TBL] [Abstract][Full Text] [Related]
25. Causal relationship between immune cells and neurodegenerative diseases: a two-sample Mendelian randomisation study.
Tang C; Lei X; Ding Y; Yang S; Ma Y; He D
Front Immunol; 2024; 15():1339649. PubMed ID: 38348026
[TBL] [Abstract][Full Text] [Related]
26. A review of Mendelian randomization in amyotrophic lateral sclerosis.
Julian TH; Boddy S; Islam M; Kurz J; Whittaker KJ; Moll T; Harvey C; Zhang S; Snyder MP; McDermott C; Cooper-Knock J; Shaw PJ
Brain; 2022 Apr; 145(3):832-842. PubMed ID: 34791088
[TBL] [Abstract][Full Text] [Related]
27. Causal association of type 2 diabetes with amyotrophic lateral sclerosis: new evidence from Mendelian randomization using GWAS summary statistics.
Zeng P; Wang T; Zheng J; Zhou X
BMC Med; 2019 Dec; 17(1):225. PubMed ID: 31796040
[TBL] [Abstract][Full Text] [Related]
28. Unbiased metabolome screen links serum urate to risk of Alzheimer's disease.
Şanlı BA; Whittaker KJ; Motsi GK; Shen E; Julian TH; Cooper-Knock J
Neurobiol Aging; 2022 Dec; 120():167-176. PubMed ID: 36206691
[TBL] [Abstract][Full Text] [Related]
29. A Mendelian Randomization-Based Causal Investigation on Bacterial Infection-Related Genes and Neurodegenerative Diseases.
Liu G; Lyu X; Wang V
Stud Health Technol Inform; 2023 Nov; 308():619-632. PubMed ID: 38007792
[TBL] [Abstract][Full Text] [Related]
30. Associations of environmental factors with neurodegeneration: An exposome-wide Mendelian randomization investigation.
Li D; Zhou L; Cao Z; Wang J; Yang H; Lyu M; Zhang Y; Yang R; Wang J; Bian Y; Xu W; Wang Y
Ageing Res Rev; 2024 Mar; 95():102254. PubMed ID: 38430933
[TBL] [Abstract][Full Text] [Related]
31. Using genetic variants to evaluate the causal effect of serum vitamin D concentration on COVID-19 susceptibility, severity and hospitalization traits: a Mendelian randomization study.
Cui Z; Tian Y
J Transl Med; 2021 Jul; 19(1):300. PubMed ID: 34246301
[TBL] [Abstract][Full Text] [Related]
32. Herpesvirus infections and Alzheimer's disease: a Mendelian randomization study.
Huang SY; Yang YX; Kuo K; Li HQ; Shen XN; Chen SD; Cui M; Tan L; Dong Q; Yu JT
Alzheimers Res Ther; 2021 Sep; 13(1):158. PubMed ID: 34560893
[TBL] [Abstract][Full Text] [Related]
33. Estimating causal effects of atherogenic lipid-related traits on COVID-19 susceptibility and severity using a two-sample Mendelian randomization approach.
Yoshikawa M; Asaba K; Nakayama T
BMC Med Genomics; 2021 Nov; 14(1):269. PubMed ID: 34774031
[TBL] [Abstract][Full Text] [Related]
34. Is disrupted sleep a risk factor for Alzheimer's disease? Evidence from a two-sample Mendelian randomization analysis.
Anderson EL; Richmond RC; Jones SE; Hemani G; Wade KH; Dashti HS; Lane JM; Wang H; Saxena R; Brumpton B; Korologou-Linden R; Nielsen JB; Åsvold BO; Abecasis G; Coulthard E; Kyle SD; Beaumont RN; Tyrrell J; Frayling TM; Munafò MR; Wood AR; Ben-Shlomo Y; Howe LD; Lawlor DA; Weedon MN; Davey Smith G
Int J Epidemiol; 2021 Jul; 50(3):817-828. PubMed ID: 33150399
[TBL] [Abstract][Full Text] [Related]
35. Mendelian randomization study to evaluate the effects of interleukin-6 signaling on four neurodegenerative diseases.
Zhang H; Wang T; Han Z; Liu G
Neurol Sci; 2020 Oct; 41(10):2875-2882. PubMed ID: 32328834
[TBL] [Abstract][Full Text] [Related]
36. Physical activities and risk of neurodegenerative diseases: A two-sample Mendelian randomization study.
Liao Q; He J; Huang K
Front Aging Neurosci; 2022; 14():991140. PubMed ID: 36212040
[TBL] [Abstract][Full Text] [Related]
37. Causal Relationships Between Relative Intake from the Macronutrients and Alzheimer's Disease: A Two-Sample Mendelian Randomization Study.
Wang X; Sun H; Pan S; Bai X; Zhu Z; Zhang R; Li C; Chen Y; Bao M; Zhang K; Feng R
J Alzheimers Dis; 2022; 87(2):665-673. PubMed ID: 35342086
[TBL] [Abstract][Full Text] [Related]
38. Mixed evidence for the relationship between periodontitis and Alzheimer's disease: A bidirectional Mendelian randomization study.
Sun YQ; Richmond RC; Chen Y; Mai XM
PLoS One; 2020; 15(1):e0228206. PubMed ID: 31978120
[TBL] [Abstract][Full Text] [Related]
39. A nonsynonymous mutation in PLCG2 reduces the risk of Alzheimer's disease, dementia with Lewy bodies and frontotemporal dementia, and increases the likelihood of longevity.
van der Lee SJ; Conway OJ; Jansen I; Carrasquillo MM; Kleineidam L; van den Akker E; Hernández I; van Eijk KR; Stringa N; Chen JA; Zettergren A; Andlauer TFM; Diez-Fairen M; Simon-Sanchez J; Lleó A; Zetterberg H; Nygaard M; Blauwendraat C; Savage JE; Mengel-From J; Moreno-Grau S; Wagner M; Fortea J; Keogh MJ; Blennow K; Skoog I; Friese MA; Pletnikova O; Zulaica M; Lage C; de Rojas I; Riedel-Heller S; Illán-Gala I; Wei W; Jeune B; Orellana A; Then Bergh F; Wang X; Hulsman M; Beker N; Tesi N; Morris CM; Indakoetxea B; Collij LE; Scherer M; Morenas-Rodríguez E; Ironside JW; van Berckel BNM; Alcolea D; Wiendl H; Strickland SL; Pastor P; Rodríguez Rodríguez E; ; ; ; ; ; ; Boeve BF; Petersen RC; Ferman TJ; van Gerpen JA; Reinders MJT; Uitti RJ; Tárraga L; Maier W; Dols-Icardo O; Kawalia A; Dalmasso MC; Boada M; Zettl UK; van Schoor NM; Beekman M; Allen M; Masliah E; de Munain AL; Pantelyat A; Wszolek ZK; Ross OA; Dickson DW; Graff-Radford NR; Knopman D; Rademakers R; Lemstra AW; Pijnenburg YAL; Scheltens P; Gasser T; Chinnery PF; Hemmer B; Huisman MA; Troncoso J; Moreno F; Nohr EA; Sørensen TIA; Heutink P; Sánchez-Juan P; Posthuma D; ; Clarimón J; Christensen K; Ertekin-Taner N; Scholz SW; Ramirez A; Ruiz A; Slagboom E; van der Flier WM; Holstege H
Acta Neuropathol; 2019 Aug; 138(2):237-250. PubMed ID: 31131421
[TBL] [Abstract][Full Text] [Related]
40. Physical activity and risk of multiple sclerosis: A Mendelian randomization study.
Li C; Lin J; Yang T; Xiao Y; Jiang Q; Shang H
Front Immunol; 2022; 13():872126. PubMed ID: 36211369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
